The positive was our ability to deliver INR 3,000 crores in revenue, which I think I talked about in Q3 that I would just like to see consistency in operations.
•
Thermax, if anything, is at the leading edge of some of these capabilities. After a year of not taking any orders, very selectively, we will start taking bio-CNG orders.
NEGATIVES
•
The quarter that went by was quite eventful. The downsides were clearly the miss on orders relative to what was committed.
•
In Q4, not only did we take INR 66 crores as a technology hit, overall, the hit on bio-CNG was more than INR 85 crores.
Peers Summary
No Peers Data
Peer comparison data is not available for this stock.